In this video, Dr. Viveka Kumar, Senior Director - Cath Lab, Max Super Speciality Hospital, Saket, will discuss the role of ticlopidine in acute MI. Ticlopidine is a drug which was used in late 90’s and nowadays it is not been used. It is also not available too. There is no role of ticlopidine in current generation unless the patient is allergic to other all antiplatelets.
Dr. Viveka Kumar is a Senior Consultant Interventional Cardiologist and Director of the Cath Lab at Max Super Speciality Hospital in Saket, New Delhi. He completed his MBBS and MD (Medicine) from IMS (BHU), Varanasi and later obtained the DM (Cardiology) postdoc, superspeciality degree through GSVM Medical College, Kanpur. Has extensive experience in the field of Cardiac interventions and Electrophysiology. Specializes in complex angioplasties including multivessel, bifurication and left main angioplasties with Rota Ablation, FFR, IVUS, IABP, IMPELLA devices. Has done more than 7500 angioplasties and 2500 balloon valvotomies with good outcomes.